Table 2 –
Unusual Instances Of Skeletal Fluorosis
| Ref no. | Author(s) | Year | Age/Sex | F-Source | Est.F-Daily Intake (mg) | Dur (yrs) | Clinical Presentation | Radiology Findings | Initial laboratory findings | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| [F] Blood X ULN | [F] Urine X ULN | [F] Tissue High | ALP X ULN | PTH X ULN | 25(OH)D ng/mL | cCa mg/dL | Cr mg/dL | |||||||||
| 27 | Klemmer & Hadler | 1978 | 27F | Inhaled anesthetic@ | DBP, CRI, SC nodules | AOS, PD, bone scan uptake | 130+ | 16+ | Bone | 4.3 | 1.6 | 13.4 | 9.8 | |||
| 35 | Fisher et al# | 1981 | F | Soil | 20 | DBP, CRI | GOS | Bone | ||||||||
| 6 | Whyte et al | 2005 | 52F | tea | 37–74 | >30 | Back pain and stiffness, joint pain, dental problems | AOS, LC, osteophytes | 5.5 | nl | nl | nl | nl | nl | ||
| 23 | Roos et al | 2005 | 45F | toothpaste | 66 | >5 | Pain, swelling of fingers, dental problems | PD, bone scan uptake | 1.7 | 16 | 3.5 | 1.3 | 20.4 | 8.8 | ||
| 22 | Hallanger et al | 2007 | 50F | tea | 56 | DBP, CRI, kyphosis, smoker | GOS | 4.8 | Bone | 17 | 12 | 9.9 | 2.1 | |||
| 67F^ | tea | 13 | Foot fracture, kyphosis, anorexia (BMI 15) | AOS | 3.9 | 1.45 | nl | 19 | 9.7 | 1.3 | ||||||
| 60F | tea + toothpaste | 17 | DBP, rib fractures, anorexia (BMI 17), smoker | AOS | 2.6 | nl | nl | 54 | 9.8 | 1.5 | ||||||
| 62F^ | tea | 14 | 30 | Joint pain, CRI, high BMD (Screening DXA) | AOS, LC | 4.3 | nl | nl | 25 | 9.9 | 1.7 | |||||
| 16 | Kurland et al | 2007 | 52M | toothpaste | Stiff neck, joint pains | AOS, LC, SSO, bone scan uptake | 1.7 | 24 | Bone | 1.8 | nl | nl | nl | 1.3 | ||
| 17 | Little et al | 2008 | 33M | Inhaled DFE | Fractures from motor vehicle accident | Exostoses, heterotopic bone | ||||||||||
| 7 | Whyte et al | 2008 | 49F | tea | 44 | 37 | DBP, LE fracture | AOS, PD, LC, bone scan uptake | 1.5 | 6.0 | Nails | 1.4 | nl | 42 | 9.1 | 1.1 |
| 8 | Izuora et al | 2011 | 48F | tea | 19–37 | 30+ | DBP, joint pain, kyphosis, smoker | GOS, LC, IOMC, SSO, STO, bone scan uptake | 2.8 | 3.3 | Nails | 3.2 | 3.1 | 11 | 9.0 | nl |
| 21 | Joshi et al | 2011 | 53F | tea+ toothpaste | 15 | Foot fracture, dental problems, cerebral palsy | AOS, LC, SSO, profuse callus | 17 | 10 | Bone Nails | nl | nl | nl | nl | ||
| 19 | Kakamanu & Sudhaker | 2013 | 47F | tea | >20 | 17 | DBP, dental problems | AOS, IOMC | 4.3 | |||||||
| 36 | Rackoff et al | 2015 | 70M | Inhaled Freon | 2 | LE nodules, heroin use, smoker | AOS, LC, SSO, STO, exostoses | 49+ | 49 | 9.5 | 1.3 | |||||
| 24 | Tucci et al* | 2017* | 28M | Inhaled DFE | 3–4 | Hip ankylosis, kyphosis, femur fracture, UE bone deformities | GOS, PD, LC, IOMC, SSO, exostoses, focal osteopenia, bone scan uptake | 2 | 5.9 | Bone | 1.8 | nl | 14 | 9.0 | ||
| 25 | Peicher & Maalouf | 2017 | 33M | Inhaled DFE | 3 | Back pain, loss of lumbar-lordosis | GOS | 14 | 2.6 | nl | 32 | 9.6 | 0.94 | |||
| 28 | Ponce et al | 2019 | 27M | Inhaled DFE | 1 | UE & LE painless nodules, syncope, frostbite | PD, exostoses | 3.8 | 16 | 5.2 | 10 | |||||
| Our Patient | 2020 | 51M | Inhaled DFE | 2–3 | DBP, fractures, obese, poor diet, opiate use, smoker | AOS, LC, IOMC, STO, osteophytes, soft tissue calcification, profuse callus, focal osteopenia, bone scan uptake | 61 | 8.5 | 4.6 | 4.2 | 21 | 7.6 | 0.7 | |||
ALP = serum alkaline phosphatase, 25OHD = serum 25 hydroxy vitamin D, AN = anorexia nervosa, AOS = axial osteosclerosis, BMD = bone mineral density , BMI = body mass index, cCa = corrected serum calcium, Cr = serum creatinine, CRI = chronic renal insufficiency, DBP = diffuse bone pain, DFE = difluoroethane in computer duster, [F] = fluoride concentration, GOS = generalized osteosclerosis, IOMC = interosseous membrane calcification, LC = ligament calcifications or ossifications, LE = lower extremity, nl = reported as normal (lab values not provided), PD = periostitis deformans, PTH = serum intact parathyroid hormone, SC = subcutaneous, SSO = sacrospinous calcification or ossification, STO = sacrotuberous ligament calcification or ossification, UE = upper extremity, X ULN = times upper limit of normal
Blank boxes indicate this information was not available.
Abstract only available.
This case was reported also by Cohen et al (ref 26) in 2014 and by Tucci et al as an ASBMR abstract 2013
Follow up on these 2 cases was reported 11 years later (ref 20)
methoxyfluoroethane
no normal range given so our assay normal range was used to estimate X ULN